Media coverage
1
Media coverage
Title Oryzon Genomics S A : announces FDA clearance of IND to initiate a collaborative Phase II basket study with iadademstat in R/R patients with Neuroendocrine carcinomas (NECs) Media name/outlet MarketScreener.com Country/Territory United States Date 11/9/22 URL https://www.marketscreener.com/quote/stock/ORYZON-GENOMICS-S-A-25531377/news/Oryzon-Genomics-S-A-announces-FDA-clearance-of-IND-to-initiate-a-collaborative-Phase-II-basket-stu-42248815/ Persons Johnathan R. Whetstine, Neena Vijayvergia